Southern Research has a history of supporting drug discovery for infectious disease. We have developed a suite of high-throughput cell-based assays measuring physiologically relevant phenotypes such as cytopathic effect and virus levels. Our 96-well human airway epithelial (HAE) model for respiratory viruses is a unique offering allowing a no-compromise solution for programs in influenza, RSV, coronavirus, and HMPV. Whether screening to identify hits or more fully characterizing leads, we can support your high-throughput discovery needs.